Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
Public ClinicalTrials.gov record NCT05322070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 4 Study of YUTIQ® (Fluocinolone Acetonide Intravitreal Implant) 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (Intraocular Inflammation Study)
Study identification
- NCT ID
- NCT05322070
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Alimera Sciences
- Industry
- Enrollment
- 125 participants
Conditions and interventions
Conditions
Interventions
- Fluocinolone Acetonide Intravitreal Implant 0.18 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 5, 2022
- Primary completion
- Oct 31, 2025
- Completion
- Oct 31, 2025
- Last update posted
- Aug 5, 2024
2022 – 2025
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Consultants of Orange County | Fullerton | California | 92835 | — |
| Macula and Retina Institute | Glendale | California | 91203 | — |
| California Eye Specialists Medical Group | Pasadena | California | 91107 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95825 | — |
| Retina Associates of Colorado | Lakewood | Colorado | 80228 | — |
| Advanced Research | Coral Springs | Florida | 33067 | — |
| Retina Specialists of Tampa | Wesley Chapel | Florida | 33544 | — |
| Marietta Eye Clinic | Marietta | Georgia | 30060 | — |
| Retinal Vitreal Consultants Ltd. | Chicago | Illinois | 60616 | — |
| Illinois Retina Associates, S.C. | Oak Park | Illinois | 60304 | — |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740 | — |
| Opthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| Massachusets Eye Research and Surgery Institution | Waltham | Massachusetts | 02451 | — |
| Foundation for Vision Research | Grand Rapids | Michigan | 49546 | — |
| Midwest Vision Research Foundation at Pepose Vision Institute | Chesterfield | Missouri | 63017 | — |
| Retina Consultants | Fargo | North Dakota | 58104 | — |
| Retina Vitreous Associates | Toledo | Ohio | 43623 | — |
| Erie Retina Research, LLC | Erie | Pennsylvania | 16507 | — |
| Tennessee Retina | Nashville | Tennessee | 37203 | — |
| Retina Consultants of Texas | Bellaire | Texas | 77401 | — |
| Retina Consultants of Texas | Katy | Texas | 77494 | — |
| Valley Retina Institute, PA | McAllen | Texas | 78503 | — |
| Medical Center Opthalmology Associates | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05322070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05322070 live on ClinicalTrials.gov.